In view of the effects observed after 1-MT treatment and the potential contribution of this pathway in preventing neurodegeneration, we also evaluated ZIKV infection in genetically modified Indoleamine 2,3-dioxigenase 1 deficient (IDO-1-/-) mice. Here, IDO1 is linked to Zika virus infectious disease.